JusticeItaly Official institution

Italy withdraws Ondansetron Accord injection authorization at manufacturer's request

Italy's medicines agency AIFA has withdrawn the authorization to sell the injectable anti-nausea medicine Ondansetron Accord, at the request of license holder Accord Healthcare, S.L.U. The decision is dated 28 October 2026. Remaining stock in the supply chain may be disposed of for one hundred and eighty days from publication.

This summary was generated by AI; the official source prevails.

What does it mean?

An injectable anti-nausea medicine is no longer approved for sale in Italy. Any stock still in circulation can be used up for a limited period after the decision is published.

Who is affected?

Patients who receive this injection, hospitals, pharmacies, and distributors holding stock of it.

What changes?

Ondansetron Accord injection and infusion syringes were previously authorized for sale in Italy; that authorization has now been withdrawn.